Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

News

  • News

    Can Low-Risk Patients with VTE Be Discharged from ED on Rivaroxabon?

    November 4, 2015

    Clinical question: Can a low-risk patient newly diagnosed with VTE in the ED be immediately discharged home on a direct factor Xa inhibitor? Background: Studies have shown that rivaroxaban incurs a risk of 2.1% in VTE recurrence and of 9.4% in clinically relevant major and non-major bleeding (in

  • News

    Coronary CT Angiography, Perfusion Imaging Effective for Evaluating Patients With Chest Pain

    November 4, 2015

    Clinical question: When evaluating the intermediate-risk patient with chest pain, should coronary computed tomography angiography (CCTA) be used instead of myocardial perfusion imaging (MPI)? Background: CCTA has been shown in prior randomized controlled trials to save time and money compared to

  • News

    ED Lung Ultrasound Useful for Differentiating Cardiogenic from Noncardiogenic Dyspnea

    November 4, 2015

    Clinical question: Is lung ultrasound a useful tool for helping to diagnose acute decompensated heart failure (ADHF)? Background: Lung ultrasound is an emerging bedside tool that has been promoted to help evaluate lung water content to help clinicians differentiate ADHF from other causes of dyspn

  • News

    When Should Hospitalists Order Continuous Cardiac Monitoring?

    November 4, 2015

    Case Two patients on continuous cardiac monitoring (CCM) are admitted to the hospital. One is a 56-year-old man with hemodynamically stable sepsis secondary to pneumonia. There is no sign of arrhythmia on initial evaluation.

  • 1
    News

    Maintenance of Certification Process Should Ensure Physicians Deliver Quality Care

    November 4, 2015

    [caption id="attachment_11777" align="alignright" width="295"] Image Credit: SHUTTERSTOCK.COM[/caption] When the American Board of Internal Medicine (ABIM) announced changes to its Maintenance of Certification (MOC) process in early 2014, the response was overwhelmingly negative.

  • News

    SHM Holding Roundtable for Hospitalist Practice Administrators

    November 4, 2015

    Are you a hospitalist practice administrator in a new role? SHM can help—and the upcoming roundtable discussion presented by Glenn Appelbaum, CHE, CPA, and Heather Fordyce, BS, on December 9 can help you find the resources to enable you to manage your practice effectively and efficiently.

  • 1
    News

    Medicare’s Readmission Reduction Program Cuts $420M to U.S. Hospitals This Year

    November 4, 2015

    It’s that time of year again … the time when hospitals around the country are being notified of their 30-day readmission penalties from the Centers for Medicare and Medicaid Services (CMS).

  • News

    Which Hospitalist Should Bill for Inpatient Stays with Multiple Providers?

    November 4, 2015

    [caption id="attachment_8354" align="alignleft" width="100"] amane kaneko[/caption] During a facility stay, a patient could be attended to by more than one hospitalist.

  • 1
    News

    Society of Hospital Medicine Launches Antimicrobial Stewardship Campaign

    November 4, 2015

    In 2006, infectious disease specialists and pharmacists at Johns Hopkins Bayview Medical Center in Baltimore took a look at the pharmacy budget and were jarred by the numbers. “The proportion of the pharmacy budget that was antimicrobials was much larger than we would expect,” says Jonathan Zenil

  • 1
    News

    Hospital Medicine Flourishing Around the World

    November 4, 2015

    Since last September, Anand Kartha, MD, MS, has headed the hospital medicine (HM) program at 600-bed Hamad General Hospital, the flagship facility for eight-hospital Hamad Medical Corporation in Doha, Qatar, a small nation of 1.8 million people located on the northeast corner of the Arabian Peninsul

Previous1 … 408 409 410 411 412 … 798Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences